INTRODUCTION {#h0.0}
============

The evolution of *Mycobacterium* species is usually driven by processes, including deletion (nonfunctional genes are deleted/inactivated and subsequently eroded), insertion (horizontal transfer and gene duplication), or a combination of these events, which aid in survival under different environmental conditions or geographic niches ([@B1][@B2][@B8]). In nature, the free-living species require larger genomes than parasitic species ([@B9], [@B10]). This trend is also clearly evident from analyses of mycobacterial genomes where a distinct pattern of decreasing genomic content is seen as one moves from nonpathogenic pathogens (NP) to opportunistic pathogens (OP) to true pathogens (TP). We therefore performed genome size analysis with 44 *Mycobacterium* strains ([Table 1](#tab1){ref-type="table"}) that represented NP, OP, and TP, and our analysis revealed that NP strains on average are bigger than those of OP and TP strains. One of the largest genomes in the *Mycobacterium* genus is that of *Mycobacterium smegmatis*, a nonpathogenic mycobacterium with approximately 6,717 protein-coding genes (genome size, 6.9 Mb). On the other extreme is a true pathogenic mycobacterium, *Mycobacterium leprae* (the leprosy bacterium), with the smallest genome, of approximately 2,770 protein-coding genes (genome size, 3.3 Mb) and approximately 1,600 functional and 1,100 nonfunctional/inactive genes ([@B11]).

###### 

Mycobacterial genomes selected for analysis

  Organism                                                        KEGG name   Yr of sequencing   No. ofgenes   Genomesize (bp)   Pathogenicity
  --------------------------------------------------------------- ----------- ------------------ ------------- ----------------- ---------------
  *Mycobacterium smegmatis* MC2 155 uid57701^[*a*](#ngtab1.1)^    msm         2006               6,938         6,988,209         NP
  *Mycobacterium smegmatis* MC2 155 uid171958                     msg         2012               6,742         6,988,208         NP
  *Mycobacterium vanbaalenii* PYR 1^[*a*](#ngtab1.1)^             mva         2006               6,136         6,491,865         NP
  *Mycobacterium* sp*.* KMS                                       mkm         2006               6,079         6,256,079         NP
  *Mycobacterium* sp*.* JLS                                       mjl         2007               5,842         6,048,425         NP
  *Mycobacterium gilvum* PYR-GCK^[*a*](#ngtab1.1)^                mgi         2007               5,669         5,982,829         NP
  *Mycobacterium* sp. MCS                                         mmc         2006               5,698         5,920,523         NP
  *Mycobacterium gilvum* Spyr1                                    msp         2010               5,552         5,783,292         NP
  *Mycobacterium indicus prani*^[*a*](#ngtab1.1)^                 mid         2012               5,318         5,589,007         NP
  *Mycobacterium* sp. JDM601                                      mjd         2011               4,398         4,643,668         NP
  *Mycobacterium tuberculosis* H37Ra                              mra         2007               4,084         4,419,977         NP
  *Mycobacterium bovis* BCG Pasteur 1173P2                        mbb         2007               4,033         4,374,522         NP
  *Mycobacterium bovis* BCG Tokyo 172                             mbt         2009               4,027         4,371,711         NP
  *Mycobacterium bovis* BCG Mexico                                mbm         2012               4,031         4,350,386         NP
  *Mycobacterium rhodesiae*                                       mrh         2012               6,336         6,415,739         OP
  *Mycobacterium chubuense*                                       mcb         2012               6,068         6,342,624         OP
  *Mycobacterium* sp. MOTT36Y                                     mmm         2012               5,177         5,613,626         OP
  *Mycobacterium intracellulare* MOTT-64                          mir         2012               5,297         5,501,090         OP
  *Mycobacterium avium* 104^[*a*](#ngtab1.1)^                     mav         2006               5,313         5,475,491         OP
  *Mycobacterium intracellulare* MOTT-02                          mit         2012               5,198         5,409,696         OP
  *Mycobacterium intracellulare* ATCC 13950^[*a*](#ngtab1.1)^     mia         2012               5,193         5,402,402         OP
  *Mycobacterium abscessus* ATCC 19977^[*a*](#ngtab1.1)^          MAb         2008               4,991         5,090,491         OP
  *Mycobacterium massiliense*                                     mmv         2012               2,680         5,068,807         OP
  *Mycobacterium avium paratuberculosis* K-10^[*a*](#ngtab1.1)^   mpa         2004               4,399         4,829,781         OP
  *Mycobacterium marinum* M^[*a*](#ngtab1.1)^                     mmi         2008               5,570         6,660,144         TP
  *Mycobacterium ulcerans*^[*a*](#ngtab1.1)^                      mul         2006               5,062         5,805,761         TP
  *Mycobacterium canettii*                                        mce         2011               3,982         4,482,059         TP
  *Mycobacterium tuberculosis* F11                                mtf         2007               3,998         4,424,435         TP
  *Mycobacterium tuberculosis* UT205                              mtd         2012               3,859         4,418,088         TP
  *Mycobacterium tuberculosis* H37Rv uid170532                    mtv         2012               4,170         4,411,708         TP
  *Mycobacterium tuberculosis* H37Rv uid57777^[*a*](#ngtab1.1)^   mtu         1998               4,062         4,411,532         TP
  *Mycobacterium tuberculosis* RGTB423                            mti         2012               3,670         4,406,587         TP
  *Mycobacterium tuberculosis* CCDC5180                           mtl         2012               3,638         4,405,981         TP
  *Mycobacterium tuberculosis* CDC1551                            mtc         2001               4,293         4,403,837         TP
  *Mycobacterium tuberculosis* KZN 605                            mtz         2012               4,071         4,399,120         TP
  *Mycobacterium tuberculosis* CCDC5079                           mte         2012               3,695         4,398,812         TP
  *Mycobacterium tuberculosis* CTRI-2                             mto         2012               4,001         4,398,525         TP
  *Mycobacterium tuberculosis* KZN 1435                           mtb         2009               4,107         4,398,250         TP
  *Mycobacterium tuberculosis* KZN 4207                           mtk         2012               4,044         4,394,985         TP
  *Mycobacterium africanum*                                       maf         2011               3,983         4,389,314         TP
  *Mycobacterium tuberculosis* RGTB327                            mtg         2012               3,739         4,380,119         TP
  *Mycobacterium bovis* AF2122/97 ^[*a*](#ngtab1.1)^              mbo         2003               4,001         4,345,492         TP
  *Mycobacterium leprae* TN^[*a*](#ngtab1.1)^                     mle         2001               2,770         3,268,203         TP
  *Mycobacterium leprae* Br4923                                   mlb         2009               2,770         3,268,071         TP

Strain used for further analyses.

*Mycobacterium indicus pranii* ([@B12]) has been shown to have novel immunomodulatory properties ([@B13][@B14][@B17]) and proven therapeutic value in the treatment of leprosy ([@B13], [@B14]). The evolution of this clinically "benevolent" bacterium has been suggested to be at the point of transition to pathogenicity ([@B12]), despite earlier data from DNA sequence analysis of select genes, *hsp70* ([EU688981](EU688981)), *gyrA* ([EU688980](EU688980)), and *dnaJ* ([EU688982](EU688982)) of *M. indicus pranii*, which showed identity (99%) with corresponding genes of *M. intracellulare*. Comparative proteomic analyses of virulence factors of *M. tuberculosis* and their homologs in 12 different mycobacterial species, including *M. indicus pranii*, point toward gene cooption as an important mechanism in the evolution of mycobacteria ([@B18]). We now describe comparative proteomic analyses of 13 species of *Mycobacterium*, including *M. indicus pranii* ([Table 2](#tab2){ref-type="table"}). The 13 *Mycobacterium* species were selected because they represented TP, OP, and NP. True pathogens, the most virulent mycobacteria, include *Mycobacterium tuberculosis*, the causative agent of human tuberculosis; *Mycobacterium bovis*, the causative agent of bovine tuberculosis; *Mycobacterium leprae*, the causative agent of leprosy, and a virulent nontuberculous mycobacterium (NTM), *Mycobacterium ulcerans*, which causes Buruli ulcers, which are the third most common mycobacterial disease in humans ([@B19]). *Mycobacterium marinum*, the causative agent of fish tank granuloma in humans and granulomatous lesions similar to those of *M. tuberculosis* in zebrafish, was also included in the true pathogen group for our analyses ([@B20], [@B21]). Opportunistic pathogens belong to the NTM group and cause pulmonary and other disseminated infections in immunocompromised individuals ([@B22]). Members of the *Mycobacterium avium* complex (MAC), *Mycobacterium avium* and *Mycobacterium avium-M. intracellulare*, cause opportunistic pulmonary infections in humans, whereas *Mycobacterium avium* subsp. *paratuberculosis*, the third member of the MAC group, is the suspected causative agent of Crohn's disease in humans ([@B22], [@B23]). *Mycobacterium abscessus* is a rapid-growing mycobacterium which causes pulmonary and cutaneous infections in immunocompromised hosts ([@B24]). The nonpathogenic group includes *Mycobacterium gilvum*, *Mycobacterium vanbaalenii*, and *Mycobacterium smegmatis*, which rarely cause disseminated infections, even in immunocompromised individuals ([@B25][@B26][@B27]). Our results convincingly establish the very upstream evolutionary position of *M. indicus pranii* and also highlight some important differences in the metabolic pathway of *M. tuberculosis* H37Rv which are of possible significance in virulence and pathogenesis.

###### 

The 13 *Mycobacterium* species included in the analyses

  *Mycobacterium* species                                KEGG alias   Categorization based on virulence   NCBI RefSeq accession no.                                                                        No. of proteins
  ------------------------------------------------------ ------------ ----------------------------------- ------------------------------------------------------------------------------------------------ -----------------
  *Mycobacterium tuberculosis* H37Rv                     MYCTU        True pathogen                       [NC_000962](NC_000962)                                                                           4,003
  *Mycobacterium bovis* subsp. *bovis* AF2122/97         MYCBO        True pathogen                       [NC_002945](NC_002945)                                                                           3,918
  *Mycobacterium leprae* TN                              MYCLE        True pathogen                       [NC_002677](NC_002677)                                                                           1,605
  *Mycobacterium ulcerans* Agy99                         MYCUA        True pathogen                       [NC_005916](NC_005916), [NC_008611](NC_008611)                                                   4,241
  *Mycobacterium marinum* M                              MYCMM        True pathogen                       [NC_010604](NC_010604), [NC_010612](NC_010612)                                                   5,452
  *Mycobacterium avium* 104                              MYCA1        Opportunistic pathogen              [NC_008595](NC_008595)                                                                           5,120
  *Mycobacterium intracellulare* ATCC 13950              MIA          Opportunistic pathogen              [NC_016946](NC_016946)                                                                           5,144
  *Mycobacterium avium* subsp. *paratuberculosis* K-10   MYCPA        Opportunistic pathogen              [NC_002944](NC_002944)                                                                           4,350
  *Mycobacterium abscessus* ATCC 19977                   MYCAB        Opportunistic pathogen              [NC_010394](NC_010394), [NC_010397](NC_010397)                                                   4,941
  *Mycobacterium indicus pranii* MTCC 9506               MIP          Nonpathogen                         [NC_018612](NC_018612)                                                                           5,254
  *Mycobacterium smegmatis* MC2 155                      MYCS2        Nonpathogen                         [NC_008596](NC_008596)                                                                           6,717
  *Mycobacterium gilvum* PYR-GCK                         MYCGI        Nonpathogen                         [NC_009338](NC_009338), [NC_009339](NC_009339), [NC_009340](NC_009340), [NC_009341](NC_009341)   5,579
  *Mycobacterium vanbaalenii* PYR-1                      MYCVP        Nonpathogen                         [NC_008726](NC_008726)                                                                           5,979

RESULTS AND DISCUSSION {#h1}
======================

Reannotation of the *M. indicus pranii* proteome. {#h1.1}
-------------------------------------------------

InterPro/Pfam domain knowledge for *M. indicus pranii* proteins was used to assign potential functions to 4,363 *M. indicus pranii* open reading frames (ORFs; \~83% of the *M. indicus pranii* proteome) ([Fig. 1](#fig1){ref-type="fig"}). Of the remaining 891 proteins, 164 were annotated using the phylogenetic classification of proteins encoded in complete genomes known as COG (Cluster of Orthologous Groups classification), but they failed to match with any domain in Pfam or InterPro. Previously, 3,870 (\~70%) of *M. indicus pranii* ORFs were assigned a putative function on the basis of COG classification ([Fig. 1](#fig1){ref-type="fig"}). Out of 1,554 hypothetical proteins in *M. indicus pranii* based on the COG annotation, 656 have been assigned a putative function based on functional domain knowledge from the InterPro/Pfam database.

![Comparative plot for annotation of *M. indicus pranii* (MIP) based on annotations in COG and InterPro/Pfam.](mbo0061420580001){#fig1}

Interestingly, 60 proteins were found to have conflicting COG- and InterPro/Pfam-based annotations. In such ambiguous cases, the protein sequences were further submitted to analysis using GENE3D to further confirm the annotation. GENE3D upheld the Pfam/InterPro annotation for all except two cases (MIP_02898 and MIP_06278), for which no hit was found in GENE3D. COG and Pfam/InterPro annotations of these 2 proteins have no link in the existing literature or protein family knowledge (see [Table S1](#tabS1){ref-type="supplementary-material"} in the supplemental material). Thus, annotating a new proteome using Interpro not only provides better annotation coverage but also increases the confidence of annotation by providing in-depth knowledge regarding domains, motifs, and a structural annotation of the given protein sequence.

Comparative genome size analysis. {#h1.2}
---------------------------------

The complete genome sequences of the 44 mycobacterial species used in our analyses were available in the public domain. The *Mycobacterium* sp*.* MOTT36Y (5,613,626 bp) represents the OP group of mycobacteria closest to *M. indicus pranii* (5,589,007 bp) in terms of genome size. Among the OP group of mycobacteria, those closest to *Mycobacterium intracellulare* (28) (5,402,402 to 5,501,090 bp) are *Mycobacterium* sp. MOTT36Y (5,613,626 bp), *Mycobacterium avium* 104 (5,475,491 bp), and *Mycobacterium abscessus* ATCC 19977 (5,090,491 bp). It is interesting that based on the genome size, the genome of *M. avium* 104, an OP, fits between *M. intracellulare* MOTT-64 (5,501,090 bp) and *M. intracellulare* MOTT-02 (5,409,696 bp) ([Fig. 2](#fig2){ref-type="fig"}).

![The genome size of NP mycobacteria is larger than that of OP and TP mycobacteria. The green box plot represents the NP genome sizes, the orange box represents OP genomes, and TP genomes are represented by the pink box, which is very tight. The red line is the regression line, and the blue line is the lowess line. The small circles denote outliers. The TP genomes were on average smaller yet variable in size. The genome plasticity for TP mycobacteria possibly highlights their abilities to evolve and survive under various environmental conditions.](mbo0061420580002){#fig2}

Sequence-based functional analysis. {#h1.3}
-----------------------------------

Homologs obtained by BLASTp analysis were assigned functional relationships by comparing their Interpro/Pfam functional domains. About 90% functional similarity between proteins can be observed if their sequences are at least 60% identical ([@B29]); neither the percentage of sequence identity nor expectation value can give complete insight into the relationship between two proteins ([@B30]). Taking these reports into account, we performed an analysis to establish functional assignments based on InterPro/Pfam domain hits to the sequence identity data of BLASTp between proteins of *M. indicus pranii* and 12 other *Mycobacterium* species ([Table 2](#tab2){ref-type="table"}; [Fig. 3A](#fig3){ref-type="fig"}). Our analyses revealed that Interpro/Pfam hits indicated *M. indicus pranii* to be most closely related to members of the *Mycobacterium avium* complex, with *M. intracellulare* and *M. avium* 104 having 77.9% and 74.9% of proteins functionally similar to those in the *M. indicus pranii* proteome, respectively. The functional relatedness of homologs fits well into the upper left corner of the receiver operating characteristics (ROC) space, indicating high sensitivity and specificity, which qualifies the functional relatedness analyses as an optimal model ([Fig. 3B](#fig3){ref-type="fig"}).

![(A) Homologs of *M. indicus pranii* proteins in 12 other *Mycobacterium* species were determined to be functionally related using InterPro/Pfam domain knowledge. (B) The ROC points are in the upper left corner, suggesting the findings are statistically significant. MIP, *M. indicus pranii.*](mbo0061420580003){#fig3}

This analysis was further used to find a BLASTp sequence identity cutoff score below which no homologs shared a functional domain. In order to correlate the BLASTp sequence identities of homologs with their functional relatedness, numbers of true positives (tp), false positives (fp), true negatives (tn), and false negatives (fn) were distributed as per BLASTp sequence identity, ranging from 0 to 100% and using 10% as the bin size. When we plotted the true-positive rate (TPR) versus a range of lower sequence identity cutoffs (0 to 100%), it was observed that below a 20% sequence identity no homologs shared functional domains (see [Fig. S1](#figS1){ref-type="supplementary-material"} in the supplemental material). This cutoff was further confirmed when we plotted the Matthews correlation coefficient (MCC) for a range of sequence identity cutoffs (0 to 100%). MCC values were zero, as calculated for the sequence identity cutoff of 20%, and exhibited a sharp rise at 30% sequence identity (see [Fig. S2](#figS2){ref-type="supplementary-material"} in the supplemental material).

For further comparative analyses, a 20% sequence identity cutoff with an e value of \<1e−4 was used to analyze BLASTp results. This cutoff was used to determine the number of homologous protein-coding genes shared between *M. indicus pranii*, *M. intracellulare* ATCC 13950, and *M. tuberculosis* H37Rv. Our analysis of homologous protein-coding genes shared between *M. indicus pranii* (NP), *M. intracellulare* ATCC 13950 (OP), and *M. tuberculosis* H37Rv (TP) revealed 4,995 (\~95%) *M. indicus pranii* proteins had homology with *M. intracellulare* ATCC 13950, whereas homologies between *M. indicus pranii*, *M. intracellulare* ATCC 13950, and *M. tuberculosis* H37Rv were significantly lower. A total of 4,153 (\~79%) *M. indicus pranii* proteins and 4,093 (\~79%) *M. intracellulare* ATCC 13950 proteins exhibited homology with the *M. tuberculosis* H37Rv proteome, while 3,301 (\~82%) and 3,295 (\~82%) *M. tuberculosis* H37Rv proteins showed homology with *M. indicus pranii* and *M. intracellulare* ATCC 13950 proteomes, respectively ([Fig. 4](#fig4){ref-type="fig"}; see also [Table S2](#tabS2){ref-type="supplementary-material"} in the supplemental material).

![Comparative genomics of selected mycobacterial genomes. The genomes of *Mycobacterium indicus pranii* (shown in green; an NP), *Mycobacterium intracellulare* ATCC 13950 (orange; an OP), and *Mycobacterium tuberculosis* H37Rv (pink; a TP) were selected for comparative genomic analyses. We used BLASTp, with a cutoff of 20% identity and e value of 10e--4, to determine the number of homologous protein-coding genes common between them (shown as edge labels between the nodes). The arrowhead represents the query genome, whereas the arrow tail represents the subject genome.](mbo0061420580004){#fig4}

Comparative metabolic pathway analyses. {#h1.4}
---------------------------------------

There were 387 enzymes (EC numbers) common between *M. intracellulare* ATCC 13950 and *M. indicus pranii* (part of the MAC complex). When these two genomes were compared to *M. tuberculosis* (part of the MTB complex), only 17 enzymes remained uniquely shared between the *M. intracellulare* ATCC 13950 and *M. indicus pranii* genomes ([Fig. 5a](#fig5){ref-type="fig"}). Compared to *M. avium* 104, only 12 enzymes remained uniquely shared between *M. intracellulare* ATCC 13950 and *M. indicus pranii* ([Fig. 5b](#fig5){ref-type="fig"}). Three enzymes, EC 1.8.7.1 (sulfite reductase \[ferredoxin\]) ([@B31]), EC 2.7.1.6 (galactokinase \[phosphorylating\]), and EC 5.4.2.8 (phospho mannose mutase) ([@B32]), were shared both between *M. intracellulare* ATCC 13950 and *M. tuberculosis* H37Rv and between *M. intracellulare* ATCC 13950 and *M. avium* 104. As these enzymes were absent from the *M. indicus pranii* genome and were shared between OP and TP, they may be linked to the pathogenesis of *Mycobacterium tuberculosis*.

![The enzymatic similarities between *M. indicus pranii* (MIP), *M. intracellulare* ATCC 13950 (MIA), *M. avium* 104 (MYCA1), and *M. tuberculosis* H37Rv (MYCTU) highlight interesting enzymatic plasticity properties. *M. intracellulare* ATCC 13950 (OP; orange) shares three enzymes (EC 1.8.7.1, sulfite reductase \[ferredoxin\]; EC 2.7.1.6, galactokinase \[phosphorylating\]; EC 5.4.2.8, phosphor mannose mutase) with *M. avium* 104 (OP; blue) and *M. tuberculosis* H37Rv (TP; red), which are absent in *M. indicus pranii* (NP; green). *M. intracellulare* ATCC 13950 and *M. indicus pranii* share 17 enzymes between them that are absent in *M. tuberculosis* H37Rv (a), while they share 12 enzymes between them that are absent in *M. avium* 104 (b).](mbo0061420580005){#fig5}

Although the genome sizes of OPs (*M. intracellulare* ATCC 13950 and *M. avium* 104) and TP (*M. tuberculosis*) are reduced compared to the genome size of *M. indicus pranii* (an NP), our analysis indicated that the OP and TP genomes have acquired few enzyme-coding genes. It is tempting to suggest a likely association between these acquired enzymes and the virulence of these OPs and TPs. One of the three shared enzymes, EC 1.8.7.1, which encodes a ferredoxin-dependent sulfite reductase (encoded by the *nirA* gene), is active during the dormant phase and has been reported to be a potential drug target for *Mycobacterium tuberculosis* ([@B33]).

Comparative metabolic pathway analysis ([Fig. 6](#fig6){ref-type="fig"}) between *M. tuberculosis*, *M. intracellulare* ATCC 13950, and *M. indicus pranii* showed the presence of alternate pathways, such as those in the fatty acid elongation pathway (*fabH* and *fabK*) and lipid biosynthesis. *M. tuberculosis* has acquired some novel pathways which involve 23 enzymes that are not present in *M. indicus pranii* or *M. intracellulare* ATCC 13950, such as those for butanoate metabolism, amino acid biosynthesis pathways, etc. ([Fig. 6](#fig6){ref-type="fig"}, shown in red). Alternate metabolic pathways must have evolved during mycobacterial evolution. *M. tuberculosis* H37Rv has few unique enzymes, which might be part of its evolutionary adaptation, and they thereby present potential drug targets. For example, gene Rv1771 (EC 1.1.3.8) is found in the ascorbate and aldarate metabolism pathways. Gene Rv3097c (EC 3.1.1.3) is an important precursor enzyme in the fatty acid pathway ([Fig. 6b and c](#fig6){ref-type="fig"}, highlighted by the cyan circle), which is absent in *M. indicus pranii* and *M. intracellulare* ATCC 13950. A few other examples include the genes Rv0069c (EC 4.3.1.17), Rv1905c (EC 1.4.3.3), Rv2192c (EC 2.4.2.18), Rv2006 (EC 3.2.1.28), Rv3393 (EC 3.2.2.1), and Rv0091 (EC 3.2.2.9), which are present in *M. tuberculosis* but absent in *M. indicus pranii* and *M. intracellulare* ATCC 13950. These genes might play an important role in the metabolism of *M. tuberculosis* as well as in the host-pathogen interaction and as a virulence factor.

![A comparative metabolic pathway analysis between *M. tuberculosis* H37Rv, *M. intracellulare* ATCC 13950, and *M. indicus pranii* reveals the presence of novel pathways in *Mycobacterium tuberculosis* that are not present in *M. indicus pranii* or *M. intracellulare* ATCC 13950. The comparative analysis of metabolic enzymes present in *M. tuberculosis* H37Rv, *M. intracellulare* ATCC 13950, and *M. indicus pranii* based on KEGG pathways are shown. (a) The unique pathways in *M. tuberculosis* H37Rv are shown in red. The common pathways between *M. intracellulare* ATCC 13950 and *M. indicus pranii* are shown in pink. The common pathways present in these three organisms are shown in black. Note that *M. tuberculosis* H37Rv has acquired alternate pathways (red) for its survival. There are few common pathways between *M. intracellulare* ATCC 13950 and *M. indicus pranii* (pink) that are absent in *M. tuberculosis* H37Rv. (b) A section (circled) of the lipid biosynthesis subpathway (glycerolipid metabolism) highlights the presence of an alternate enzyme (EC 3.1.1.3, Rv3097c) that performs molecular transformations in *M. tuberculosis* H37Rv. (c) A section (circled) of the lipid biosynthesis subpathway (fatty acid metabolism) highlights an alternate enzyme (FabH gene) present in *M. intracellulare* ATCC 13950 and *M. indicus pranii* but absent in *M. tuberculosis* H37Rv.](mbo0061420580006){#fig6}

Conclusions. {#h1.5}
------------

The COG method of proteome annotation is based on assignment of a sequence-based orthology, whereas function prediction tools like InterPro add to in-depth annotation of a gene by utilizing the domain and signature knowledge. We found that COG-based annotation of the *M. indicus pranii* proteome consisted of some ambiguous cases compared with other protein domain databases that are used for annotation. The combination of homology-based COG and a functional domain database like InterPro/Pfam provided the maximum coverage for annotating a proteome. The protein domain knowledge available using InterPro/Pfam and the Conserved Domains Database (CDD) can help associate sequence-based homologs with the functional orthologs. From the above approach, we found that among mycobacterial species, for a protein to be a homolog, its sequence identity should be above 20%. We have also highlighted here the importance of comparative genomics and protein domains by curating 60 misannotated *M. indicus pranii* genes in the public database (see [Table S1](#tabS1){ref-type="supplementary-material"} in the supplemental material).

Our comparative genomic and proteomic analyses of pathogenic and nonpathogenic mycobacterial species provided strong evidence suggesting that despite having identical rRNA genes (except for notable differences in the 23S rRNA gene) with *M. intracellulare*, *M. indicus pranii* (an NP with strong immunomodulatory properties) is a predecessor of the *M. avium* complex ([@B12]) and is at an evolutionarily transitory position with respect to a fast versus slow grower and as a saprophyte versus a seasoned pathogen ([@B6], [@B12]). During the process of evolution, *M. indicus pranii* evolved into *M. intracellulare* ATCC 13950 (an OP) when a few genes were deleted and a few enzyme-encoding genes were acquired (which may provide a common/evolutionary link between *M. avium* 104 \[OP\] and *M. intracellulare* ATCC 13950 \[OP\]). A similar pattern as with *M. intracellulare* ATCC 13950 is exhibited by *Mycobacterium tuberculosis*, where a large portion of genes with a conserved proline-glutamate (PE) motif or proline-proline-glutamate motif (PPE) family have been acquired ([@B5]), although most of them are still hypothetical proteins. Although we know that members of the PE/PPE gene family code for virulence factors ([@B4], [@B34][@B35][@B36]), it will be interesting if some of these hypothetical proteins have any enzymatic function, as until now only one PE protein, PE30 (Rv3097c), has been reported to exhibit enzymatic activity ([@B37]). Such proteins can be exploited for antituberculosis drug therapy. The host-pathogen interaction network between *M. tuberculosis* and humans ([@B38]) might provide some insight into the evolutionary pressure under which *M. tuberculosis* obtained a new set of pathways for its survival, which can be exploited again for antituberculosis interventions. Furthermore, our findings on the presence of alternative metabolic pathways in *Mycobacterium tuberculosis* pose important questions about their role in virulence and the consequent implications for designing new interventions against tuberculosis.

MATERIALS AND METHODS {#h3}
=====================

Reannotation of the *M. indicus pranii* proteome. {#h3.1}
-------------------------------------------------

The prediction of protein function domains for the ORFs of *M. indicus pranii* was carried out using InterPro ([@B39], [@B40]) and Pfam ([@B41]). The domain hits of individual proteins were compared to annotations of the COG database ([@B42]). As InterProscan uses CATH GENE3D version 3.3.0 ([@B43]), in cases of ambiguity the protein sequences were submitted to GENE3D v11.0 and the Domain Enhanced Lookup Time Accelerated BLAST (DELTA-BLAST) system ([@B44]) to confirm the annotation.

Functional relatedness of homologs. {#h3.2}
-----------------------------------

A sequence identity above 60% between two proteins is required to have 90% functional similarity ([@B29]); however, neither the sequence identity nor the expectation value can give complete insight into the relationship between two proteins ([@B30]). We therefore tried to relate the functional similarity based on Interpro/Pfam domain hits to the coverage and sequence identity of BLASTp results between *M. indicus pranii* and other *Mycobacterium* species. To show the functional relationships between homologs, we assigned a value of 1 for a positive functional relationship if the homologs shared at least one InterPro/Pfam ID and a value of 0 if they shared none, indicating no functional relationship.

The statistical significance of our approach was determined using data from DELTA-BLAST, which returns the domain hits of a protein from the CDD. For each homolog pair, we assigned a value of 1 if they shared at least one conserved domain and a value of 0 if they did not share any conserved domain listed in the CDD. The findings from the above two lists (InterPro/Pfam and CDD) were compared to calculate the number of tp, tn, fp, and fn (see Chart S1 in the supplemental material), which were used to plot ROC curves.

In order to obtain a sequence identity cutoff below which no functional similarity or homologs were observed in the *Mycobacterium* genus (13 species included in the analyses), we plotted the number of tp against sequence identity (varying from 0% to 100%) for *M. indicus pranii* versus all 12 *Mycobacterium* other species (see [Fig. S1](#figS1){ref-type="supplementary-material"} in the supplemental material). Furthermore, MCC values were calculated for sequence identity cutoffs ranging from 0 to 100% (see [Fig. S2](#figS2){ref-type="supplementary-material"} in the supplemental material). We also performed all-against-all BLASTp-based homology searches for 13 *Mycobacterium* species, using a sequence identity cutoff of 20% and an e value of \<1e−04 ([@B45]).

Comparative metabolic pathway analyses. {#h3.3}
---------------------------------------

Analysis of metabolic enzymes was carried out based on the IUBMB EC numbers ([@B46]) in the KEGG database ([@B47]) (accessed in December 2012) for *M. indicus pranii* (387 EC enzymes), *M. intracellulare* ATCC 13950 (394 EC), *M. avium* 104 (413 EC), and *M. tuberculosis* (396 EC) genomes ([@B48]). Comparative metabolic pathway analysis between *M. tuberculosis*, *M. intracellulare* ATCC 13950, and *M. indicus pranii* was performed using iPath2.0 ([@B49]).

SUPPLEMENTAL MATERIAL {#h4}
=====================

###### 

Chart summarizing the bases for statistical analyses. Download

###### 

Chart S1, TIF file, 1.3 MB

###### 

Correlation of BLASTp sequence identities between homologs of *M. indicus pranii* proteins in 12 other *Mycobacterium* species with their functional relatedness (Interpro/Pfam). Plots of the number of true positives among the total number of homologs versus various sequence identities showed that below a 20% sequence identity cutoff, no functional similarity between homologs was observed for *Mycobacterium* species. Download

###### 

Figure S1, TIF file, 1.8 MB

###### 

Correlation for BLASTp sequence identities between homologs of *M. indicus pranii* proteins in 12 other *Mycobacterium* species, with their functional relatedness (Interpro/Pfam). Mathews correlation coefficient values were plotted for various sequence identity cutoffs. MCC values are 0 for sequence identity cutoffs of 0 to 20% and show a steep rise at 30% sequence identity, suggesting that below the 20% sequence identity cutoff no functional similarity between homologs can be observed for *Mycobacterium* species. Download

###### 

Figure S2, TIF file, 1.6 MB

###### 

List of ambiguous cases found while reannotating the *M. indicus pranii* proteome based on InterPro domains

###### 

Table S1, DOCX file, 0.02 MB.

###### 

Mycobacterial genomes selected for comparative genomics analysis

###### 

Table S2, DOCX file, 0.01 MB.
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